Pharmaceutical Biotechnology Center

Research Summary

The Pharmaceutical Biotechnology Center addresses human and animal health concerns through development of bio-therapeutics (monoclonal antibodies, peptides, proteins) and vaccines, with emphasis on cardiometabolic diseases, diabetes and nutritional health.

The objectives are to:

1. Establish integrated capabilities for preclinical assessment and clinical lead development of bio-therapeutics and vaccines in collaboration with academic researchers or industrial customers;
2. Become the preferred partner and a conduit for pharmaceutical product development bridging academia and industry;
3. Become a preferred partner for industries for the discovery as well as product and pipeline development; and
4. Become an economic engine facilitating therapeutics development and startup businesses.